drugset / Trial / NCT01830881

Evaluation of Oral Midazolam in First-trimester Surgical Abortions

NCT01830881 ↗

Phase 4 Completed 124 enrolled Oregon Health and Science University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the level of pain, anxiety and side effects that women experience with a surgical abortion and the effect that the anti-anxiety medication, midazolam, might have when used along with ibuprofen and a paracervical block (PCB) instead of the standard pain treatment of only ibuprofen and a PCB.

Timeline

Start
2013-04
Primary completion
2013-12
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 10 mg Oral
Comparator Ibuprofen Small molecule 800 mg Oral
Comparator Lidocaine Other / unclassified 1 % Other
Comparator Lidocaine Other / unclassified 20 ml Other

Indications